Tumor suppressor maspin as a modulator of host immune response to cancer

Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer i...

Full description

Saved in:
Bibliographic Details
Published in:Bosn J Basic Med Sci
Main Authors: Dzinic, Sijana H., Bernardo, M. Margarida, Oliveira, Daniel S. M., Wahba, Marian, Sakr, Wael, Sheng, Shijie
Format: Artigo
Language:Inglês
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2015
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690435/
https://ncbi.nlm.nih.gov/pubmed/26614844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2015.783
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items